On May 07, 2026, DNA reported earnings of -1.39 USD per share (EPS) for Q1 26, missing the estimate of -1.09 USD, resulting in a -27.43% surprise. Revenue reached 25.68 million, compared to an expected 41.94 million, with a -38.75% difference. The market reacted with a -13.47% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.